Ideaya Biosciences Inc (NASDAQ:IDYA) price on Thursday, April 10, fall -0.06% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $15.77.
A look at the stock’s price movement, the close in the last trading session was $15.78, moving within a range at $14.47 and $16.0. The beta value (5-Year monthly) was 0.506. Turning to its 52-week performance, $44.42 and $13.45 were the 52-week high and 52-week low respectively. Overall, IDYA moved -15.22% over the past month.
Ideaya Biosciences Inc’s market cap currently stands at around $1.38 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-12.
Wall Street analysts have also projected the company’s year-on-year revenue to grow to 16.22M, representing a 131.71% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that IDYA is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
11 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 10 recommend IDYA as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
IDYA’s current price about -6.88% and -18.80% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 40.49, while 7-day volatility ratio is 13.70% and 7.91% in the 30-day chart. Further, Ideaya Biosciences Inc (IDYA) has a beta value of 0.30, and an average true range (ATR) of 1.40. Analysts have given the company’s stock an average 52-week price target of $38.5, forecast between a low of $27 and high of $50. Looking at the price targets, the low is -71.21% off current price level while to achieve the yearly target high, price needs to move -217.06%. Nonetheless, investors will most likely welcome a -144.13% jump to $38.5 which is the analysts’ median price.
If we refocus on Ideaya Biosciences Inc (NASDAQ:IDYA), historical trading data shows that trading volumes averaged 2.11 over the past 10 days and 1.07 million over the past 3 months. The company’s latest data on shares outstanding shows there are 86.50 million shares.
The 7.65% of Ideaya Biosciences Inc’s shares are in the hands of company insiders while institutional holders own 100.87% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 9.88 million on 2025-03-14, giving us a short ratio of 10.31. The data shows that as of 2025-03-14 short interest in Ideaya Biosciences Inc (IDYA) stood at 1257.0 of shares outstanding, with shares short rising to 8.9 million registered in 2025-02-14. Current price change has pushed the stock -38.64% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the IDYA stock continues to rise going into the next quarter.
